Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Noguchi, Miyako  [Clear All Filters]
Journal Article
Mao Z, Nesterenko PA, McLaughlin J, Deng W, Sojo GBurton, Cheng D, Noguchi M, Chour W, DeLucia DC, Finton KA, et al. Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation. Proc Natl Acad Sci U S A. 2022;119(31):e2203410119.
Pan Y, Phillips JW, Zhang BD, Noguchi M, Kutschera E, McLaughlin J, Nesterenko PA, Mao Z, Bangayan NJ, Wang R, et al. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing. Proc Natl Acad Sci U S A. 2023;120(21):e2221116120.
Nesterenko PA, McLaughlin J, Tsai BL, Sojo GBurton, Cheng D, Zhao D, Mao Z, Bangayan NJ, Obusan MB, Su Y, et al. HLA-A02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Rep. 2021:110167.
Bangayan NJ, Wang L, Sojo GBurton, Noguchi M, Cheng D, Ta L, Gunn D, Mao Z, Liu S, Yin Q, et al. Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy. Proc Natl Acad Sci U S A. 2023;120(47):e2312374120.
Koo D, Mao Z, Dimatteo R, Noguchi M, Tsubamoto N, McLaughlin J, Tran W, Lee S, Cheng D, de Rutte J, et al. Defining T cell receptor repertoires using nanovial-based binding and functional screening. Proc Natl Acad Sci U S A. 2024;121(14):e2320442121.